Syndecan-1 Is Required for Robust Growth, Vascularization, and Metastasis of Myeloma Tumors in Vivo
Open Access
- 18 September 2009
- journal article
- Published by Elsevier BV
- Vol. 284 (38), 26085-26095
- https://doi.org/10.1074/jbc.m109.018473
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Heparanase Stimulation of Protease Expression Implicates It as a Master Regulator of the Aggressive Tumor Phenotype in MyelomaJournal of Biological Chemistry, 2008
- The role of microenvironment in tumor angiogenesisGenes & Nutrition, 2008
- Glypican-1 modulates the angiogenic and metastatic potential of human and mouse cancer cellsJCI Insight, 2008
- Syndecan-1: a dynamic regulator of the myeloma microenvironmentClinical & Experimental Metastasis, 2007
- Extravasation and homing mechanisms in multiple myelomaClinical & Experimental Metastasis, 2007
- The syndecan-1 heparan sulfate proteoglycan is a viable target for myeloma therapyBlood, 2007
- Synopsis of a Roundtable on Validating Novel Therapeutics for Multiple MyelomaClinical Cancer Research, 2006
- Enhancement of clonogenicity of human multiple myeloma by dendritic cellsThe Journal of Experimental Medicine, 2006
- Heparan sulphate proteoglycans are essential for the myeloma cell growth activity of EGF-family ligands in multiple myelomaOncogene, 2006
- The syndecan-1 ectodomain regulates αvβ3 integrin activity in human mammary carcinoma cellsThe Journal of cell biology, 2004